Skip to content
Inciteful Med

Growth, Development, and Long-Term Outlook

Last updated:

Individuals with Down syndrome now have a median life expectancy of about 60 years. While they face a higher risk of Alzheimer's disease later in life due to the APP gene, regular exercise, social engagement, and lifelong learning can build cognitive resilience and support brain health.

Key Takeaways

  • • The median life expectancy for individuals with Down syndrome is now approximately 60 years.
  • • Development continues throughout life, with many adults achieving autonomy, supported living, or competitive employment.
  • • An extra copy of the APP gene on the 21st chromosome increases the risk of Alzheimer’s disease later in life.
  • • Early signs of Alzheimer's in Down syndrome often present as behavioral changes or loss of executive function rather than memory loss.
  • • Regular physical activity, cognitive stimulation, and strong social networks help build cognitive resilience against age-related decline.

The long-term outlook for individuals with Down syndrome has been completely reimagined over the last few decades. Today, with early intervention and specialized medical care, many adults with Down syndrome lead fulfilling lives, participate in their communities, and reach a median life expectancy of approximately 60 years [1][2]. While every individual faces a unique journey, understanding the typical patterns of growth and aging can help you prepare for a successful future.

Cognitive and Developmental Trajectory

All individuals with Down syndrome experience some degree of intellectual disability, typically in the mild-to-moderate range (with an average IQ around 50) [3]. However, “IQ” is only one measure of a person’s capability.

  • Strengths: Many individuals show strong social-emotional skills, a great capacity for empathy, and strong visual memory [4].
  • Growth: Development continues throughout life. While milestones like walking and talking occur later than in typical peers, they follow the same sequence [5][6].
  • Neurodiversity: The goal of modern support is to foster autonomy (the ability to make one’s own choices) and independence, whether that means competitive employment, supported living, or active community engagement [7][8].

Understanding the Risk of Alzheimer’s Disease

It is important to be aware that individuals with Down syndrome are at a higher risk for Alzheimer’s disease (AD) later in life. This is a biological reality tied to the extra 21st chromosome, which contains the APP gene (Amyloid Precursor Protein) [9]. Because people with Down syndrome have three copies of this gene instead of two, they produce an excess of amyloid-beta, a protein that forms “plaques” in the brain [10][11].

While microscopic brain changes associated with this gene can begin to appear by age 40, it is crucial to understand that clinical symptoms of dementia typically do not appear until their late 40s, 50s, or beyond, giving your child decades of vibrant, active life before this becomes a concern [9][11].

  • Early Signs: In the Down syndrome population, the first signs of AD may not be memory loss, but rather changes in behavior, such as new irritability, loss of interest in hobbies, or a decline in “executive function” (planning and organizing) [12][13].

Building “Cognitive Resilience”

While the genetic risk for Alzheimer’s is high, research shows that lifestyle factors can help build cognitive resilience—the brain’s ability to function well despite the presence of pathology [14].

  • Physical Activity: Regular moderate-to-vigorous exercise is associated with a slower rate of cognitive decline and better memory performance in adults with Down syndrome [15][14][16].
  • Cognitive Stimulation: Engaging in meaningful work, social activities, and lifelong learning helps maintain brain health [17].
  • Supplements and Research: Some emerging research explores the use of specific supplements, like EGCG (a green tea extract), combined with cognitive training to support memory [18][19]. (Note: Parents should never start unregulated supplements without consulting their pediatrician, as their safety and efficacy are still being studied, and vulnerable new parents are often targeted by ‘miracle cure’ marketing.)
  • Social Support: A strong social network and a high quality of life for both the individual and their caregivers are among the most powerful predictors of long-term well-being [4][20].

By focusing on a healthy lifestyle and staying connected with a specialized medical team, individuals with Down syndrome can continue to grow, learn, and contribute to their communities well into their senior years.

Frequently Asked Questions

What is the life expectancy for someone with Down syndrome?
With modern medical care and early intervention, the median life expectancy for individuals with Down syndrome is now approximately 60 years. Many adults lead fulfilling, active lives and participate in their communities.
Why is Alzheimer's disease more common in people with Down syndrome?
Individuals with Down syndrome have an extra copy of the 21st chromosome, which contains the APP gene. This gene produces an excess of amyloid-beta, a protein that forms plaques in the brain, increasing the risk of developing Alzheimer's disease.
What are the early signs of Alzheimer's in adults with Down syndrome?
The first signs are often behavioral rather than memory-related. You may notice new irritability, a loss of interest in favorite hobbies, or a decline in executive function, which involves planning and organizing skills.
How can we support brain health and cognitive resilience as my child ages?
Regular physical activity, meaningful social engagement, and lifelong learning are key to building cognitive resilience. A healthy, active lifestyle can help slow cognitive decline and improve memory performance as your child ages.
When do clinical symptoms of dementia usually appear in Down syndrome?
While microscopic changes in the brain related to the APP gene can begin around age 40, clinical symptoms of dementia typically do not become apparent until a person is in their late 40s, 50s, or beyond.

Questions for Your Doctor

  • • What baseline cognitive assessments should we have on file for my child as they enter adulthood?
  • • Starting at age 40, what are the specific 'red flags' for Alzheimer's that we should look for in someone with Down syndrome?
  • • Can we discuss the role of the APP gene and how it affects my child's long-term brain health?
  • • Are there local specialists or clinics that focus on the 'transition to adulthood' for individuals with Down syndrome?
  • • What are the current recommendations for physical activity and diet to support my child's cognitive resilience as they age?

Questions for You

  • • What does 'independence' look like for my child in 10, 20, or 30 years, and how can we start building those skills now?
  • • How am I supporting my own health and well-being so I can continue to be a strong advocate for my child?
  • • What are my child's greatest strengths (e.g., social skills, routine-following, creative arts), and how can we leverage them for future employment or hobbies?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Down syndrome-A narrative review with a focus on anatomical features.

    Arumugam A, Raja K, Venugopalan M, et al.

    Clinical anatomy (New York, N.Y.) 2016; (29(5)):568-77 doi:10.1002/ca.22672.

    PMID: 26599319
  2. 2

    Cardiovascular disease in Down syndrome.

    Versacci P, Di Carlo D, Digilio MC, Marino B

    Current opinion in pediatrics 2018; (30(5)):616-622 doi:10.1097/MOP.0000000000000661.

    PMID: 30015688
  3. 3

    Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer's disease-related dysregulation.

    Haertle L, Müller T, Lardenoije R, et al.

    Clinical epigenetics 2019; (11(1)):195 doi:10.1186/s13148-019-0787-x.

    PMID: 31843015
  4. 4

    Thriving with Down syndrome: A qualitative multiple case study.

    Thompson T, Talapatra D, Hazel CE, et al.

    Journal of applied research in intellectual disabilities : JARID 2020; (33(6)):1390-1404 doi:10.1111/jar.12767.

    PMID: 32538538
  5. 5

    Is the Age of Developmental Milestones a Predictor for Future Development in Down Syndrome?

    Locatelli C, Onnivello S, Antonaros F, et al.

    Brain sciences 2021; (11(5)) doi:10.3390/brainsci11050655.

    PMID: 34069813
  6. 6

    A schedule of gross motor development for children with Down syndrome.

    Winders P, Wolter-Warmerdam K, Hickey F

    Journal of intellectual disability research : JIDR 2019; (63(4)):346-356 doi:10.1111/jir.12580.

    PMID: 30575169
  7. 7

    Down syndrome and infertility: what support should we provide?

    Parizot E, Dard R, Janel N, Vialard F

    Journal of assisted reproduction and genetics 2019; (36(6)):1063-1067 doi:10.1007/s10815-019-01457-2.

    PMID: 31073724
  8. 8

    Employment of people with Down syndrome: A scoping review.

    Ting CH, Rahman MM, Chen YY, et al.

    Narra J 2024; (4(3)):e1431 doi:10.52225/narra.v4i3.1431.

    PMID: 39816059
  9. 9

    Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP.

    Wiseman FK, Pulford LJ, Barkus C, et al.

    Brain : a journal of neurology 2018; (141(8)):2457-2474 doi:10.1093/brain/awy159.

    PMID: 29945247
  10. 10

    Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models.

    Tosh JL, Rhymes ER, Mumford P, et al.

    Scientific reports 2021; (11(1)):5736 doi:10.1038/s41598-021-85062-3.

    PMID: 33707583
  11. 11

    The Search for Biomarkers of Alzheimer's Disease in Down Syndrome.

    Handen BL

    American journal on intellectual and developmental disabilities 2020; (125(2)):97-99 doi:10.1352/1944-7558-125.2.97.

    PMID: 32058812
  12. 12

    The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies.

    Lautarescu BA, Holland AJ, Zaman SH

    Neuropsychology review 2017; (27(1)):31-45 doi:10.1007/s11065-017-9341-9.

    PMID: 28289920
  13. 13

    The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome.

    Dekker AD, Sacco S, Carfi A, et al.

    Journal of Alzheimer's disease : JAD 2018; (63(2)):797-819 doi:10.3233/JAD-170920.

    PMID: 29689719
  14. 14

    Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's disease.

    Fleming VL, Peven J, Helsel BC, et al.

    Alzheimer's & dementia (New York, N. Y.) 2025; (11(3)):e70127 doi:10.1002/trc2.70127.

    PMID: 40584896
  15. 15

    The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer's Disease in Down Syndrome.

    Pape SE, Baksh RA, Startin C, et al.

    Journal of clinical medicine 2021; (10(9)) doi:10.3390/jcm10091882.

    PMID: 33925348
  16. 16

    The joint association of obesity and physical activity on cognitive function in Down syndrome.

    Clina JG, Helsel BC, Hartley SL, et al.

    Journal of Alzheimer's disease : JAD 2025; (108(3)):1328-1338 doi:10.1177/13872877251386474.

    PMID: 41100837
  17. 17

    Lifestyle Composite and Resilience to Alzheimer's Disease Pathology in Down Syndrome.

    Schworer EK, Zammit MD, Handen BL, et al.

    Journal of applied research in intellectual disabilities : JARID 2025; (38(4)):e70109 doi:10.1111/jar.70109.

    PMID: 40799171
  18. 18

    Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.

    de la Torre R, de Sola S, Hernandez G, et al.

    The Lancet. Neurology 2016; (15(8)):801-810 doi:10.1016/S1474-4422(16)30034-5.

    PMID: 27302362
  19. 19

    DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down Syndrome.

    Feki A, Hibaoui Y

    Brain sciences 2018; (8(10)) doi:10.3390/brainsci8100187.

    PMID: 30332747
  20. 20

    Health-related quality of life and family functioning of primary caregivers of children with down syndrome.

    Rozensztrauch A, Wieczorek K, Twardak I, Śmigiel R

    Frontiers in psychiatry 2023; (14()):1267583 doi:10.3389/fpsyt.2023.1267583.

    PMID: 38161724

This page provides educational information about the long-term development and aging process in Down syndrome. It does not replace professional medical advice; always consult your doctor regarding your child's specific cognitive and health needs.

Stay up to date

Get notified when new research about Down syndrome is published.

No spam. Unsubscribe anytime.